Group B streptococcal infection epidemiology and demographics
Group B Streptococcal Infection Microchapters |
Differentiating Group B Streptococcal Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Group B streptococcal infection epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Group B streptococcal infection epidemiology and demographics |
FDA on Group B streptococcal infection epidemiology and demographics |
CDC on Group B streptococcal infection epidemiology and demographics |
Group B streptococcal infection epidemiology and demographics in the news |
Blogs on Group B streptococcal infection epidemiology and demographics |
Directions to Hospitals Treating Group B streptococcal infection |
Risk calculators and risk factors for Group B streptococcal infection epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [4]
Overview
Before active prevention was initiated, an estimated 7,500 cases of neonatal Group B streptococcal (GBS) disease occurred annually in the United States.[1] Striking declines in disease incidence coincided with increased prevention activities in the 1990s,[2] and a further reduction occurred following the issuance of the recommendation for universal screening in 2002.[3] However, GBS disease remains the leading infectious cause of morbidity and mortality among newborns in the United States.[4][5] The continued burden of disease and newly available data relevant to early-onset GBS disease prevention from the fields of epidemiology, obstetrics, neonatology, microbiology, molecular biology, and pharmacology prompted revision of the guidelines for early-onset GBS disease prevention.[6]
References
- ↑ Zangwill KM, Schuchat A, Wenger JD (1992). "Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system". MMWR CDC Surveill Summ. 41 (6): 25–32. PMID 1470102.
- ↑ Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB; et al. (2000). "Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis". N Engl J Med. 342 (1): 15–20. doi:10.1056/NEJM200001063420103. PMID 10620644.
- ↑ CDC. Perinatal group B streptococcal disease after universal screening recommendations---United States, 2003--2005. MMWR 2007;56:701--5.[1]
- ↑ Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S; et al. (2008). "Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005". JAMA. 299 (17): 2056–65. doi:10.1001/jama.299.17.2056. PMID 18460666.
- ↑ CDC. Trends in perinatal group B streptococcal disease---United States, 2000--2006. MMWR 2009;58:109--12.[2]
- ↑ Verani J.R., McGee L, and Schrag S.J. Prevention of Perinatal Group B Streptococcal Disease. Revised Guidelines from CDC, 2010.CDC.gov